Our dedicated technology transfer team collaborates closely with businesses of all sizes—from early startups to established corporations—to research and develop solutions that address their specific needs and challenges.
Below you’ll find a selection of industry collaborations supported by diverse funding types, carried out with companies of all sizes and sectors, and spanning projects of varying durations.

Funding: tender / call for project by Eurocontrol
• Project collaboration with three partners, Eurocontrol France, Skysoft Swiss and Idiap
• Joint development of technology for pseudo-pilot simulator, i.e., voice enabled technologies, which can replace real pilots by a machine in ATC simulator.
• Development of voice-enabled technologies, integrated into the overall architecture of pseudo-pilot simulator. The technology is now under testing.

Funding: The Ark NPR, 18 months
• In collaboration with Inflamalps.
• The project aimed to develop an NLP software infrastructure to support biomedical discovery using large-scale textual interpretation over scientific text (papers and patents).
• The project developed a sophisticated NLP platform that uses Large Language Models (LLMs) and knowledge graphs to analyze massive scientific datasets, enabling the automated extraction and structuring of complex biomedical relationships.
• For Inflammalps, this platform accelerates antibiotic discovery by autonomously sifting through vast literature to identify potential new drugs and targets, allowing them to significantly reduce research time, minimize resource waste, and focus on the most promising compounds

Funding: Innosuisse, 18-month collaborative research project



Collaborations between Idiap and industry are governed by a set of standard agreement models. Each model defines the scope of work, IP ownership, publication rights, and applicable costs. The appropriate agreement depends on the nature of the collaboration.
We offer several types of agreements to structure collaborations with industry:
Swiss-based companies can access Innosuisse funding to co-finance research collaborations with Idiap. Full eligibility conditions and application guidance are available at innosuisse.guide
Priority right to file patent applications for company with exclusive right in a field of use. Company has a non-exclusive license on the software.
According to project application. Hourly rates are fixed by Innosuisse.
Innosuisse covers Idiap's salary costs; the company is required to contribute 40% in-kind and 5% in cash.
Startups and SMEs established in Valais may be eligible for collaboration funding through TheArk. This funding can support a joint research project between your company and Idiap.
IP conditions depend on the type of The Ark funding (innovation project, maturation project, NPR, ...).
Costs cover involved resource salaries plus 17% social charges and 30% overhead.
Companies can directly fund a research project at Idiap through a research mandate, without requiring external funding such as Innosuisse or TheArk. It can also sponsor a PhD student for more fundamental research project.
All results are owned by the company. Idiap retains the right to publish or present scientific findings.
Costs cover involved resource salaries plus 17% social charges and 30% overhead
Companies seeking a long-term research partnership with Idiap can establish a framework agreement covering multiple projects over several years, with predefined conditions for each collaboration.
IP conditions are defined on a case-by-case basis during preparation of the framework agreement
The company defines an annual budget envelope covering one or more projects. Costs follow the same structure: involved resource salaries plus 17% social charges and 20% overhead.
Voluntary gift from a company for research support and discovery of new exciting technologies
Idiap remains the owner of the IPR. No benefit for the company, except acknowledgment of the funding
0% overhead




